Libenzapril

CAS No. 109214-55-3

Libenzapril( —— )

Catalog No. M34314 CAS No. 109214-55-3

Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 592 In Stock
10MG 843 In Stock
25MG 1264 In Stock
50MG 1655 In Stock
100MG 2260 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Libenzapril
  • Note
    Research use only, not for human use.
  • Brief Description
    Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
  • Description
    Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    ACE
  • Recptor
    Angiotensin-converting Enzyme (ACE)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109214-55-3
  • Formula Weight
    363.41
  • Molecular Formula
    C18H25N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(O)=O)N1C=2C(CC[C@H](N[C@@H](CCCCN)C(O)=O)C1=O)=CC=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Abz-FR-K(Dnp)-P-OH

    Excellent angiotensin I-converting enzyme (ACE) substrate with a Km value of 4.0 μM and a kcat value of 210s-1.

  • Ilepatril

    A potent, dual ACE-neutral endopeptidase (vasopeptidase) inhibitor with IC50 of 0.053 and 5.0 nM, respectively.

  • Lisinopril dihydrate

    A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.